Integrated Quantitative Investments LLC Acquires New Shares in Owens & Minor, Inc. (NYSE:OMI)

Integrated Quantitative Investments LLC bought a new stake in Owens & Minor, Inc. (NYSE:OMI - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 59,800 shares of the company's stock, valued at approximately $782,000. Integrated Quantitative Investments LLC owned 0.08% of Owens & Minor as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Inspire Advisors LLC increased its holdings in shares of Owens & Minor by 11.2% in the fourth quarter. Inspire Advisors LLC now owns 15,350 shares of the company's stock valued at $201,000 after purchasing an additional 1,548 shares during the last quarter. Blue Trust Inc. grew its stake in Owens & Minor by 57.4% in the 4th quarter. Blue Trust Inc. now owns 4,387 shares of the company's stock valued at $57,000 after buying an additional 1,600 shares during the last quarter. KBC Group NV raised its holdings in Owens & Minor by 98.2% in the 4th quarter. KBC Group NV now owns 4,434 shares of the company's stock valued at $58,000 after acquiring an additional 2,197 shares during the period. Linden Thomas Advisory Services LLC lifted its position in Owens & Minor by 16.3% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 26,302 shares of the company's stock worth $344,000 after acquiring an additional 3,688 shares during the last quarter. Finally, Franklin Resources Inc. boosted its holdings in shares of Owens & Minor by 6.5% during the third quarter. Franklin Resources Inc. now owns 61,223 shares of the company's stock worth $961,000 after acquiring an additional 3,743 shares during the period. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Robert W. Baird lifted their price target on Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. JPMorgan Chase & Co. dropped their target price on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a report on Monday, March 10th. Finally, UBS Group decreased their price target on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research note on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Owens & Minor has a consensus rating of "Hold" and a consensus target price of $13.75.

Insider Buying and Selling at Owens & Minor

In other Owens & Minor news, major shareholder Coliseum Capital Management, L bought 354,901 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $9.19 per share, for a total transaction of $3,261,540.19. Following the completion of the transaction, the insider now directly owns 9,824,599 shares in the company, valued at approximately $90,288,064.81. The trade was a 3.75 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders bought a total of 2,493,412 shares of company stock worth $22,832,558 over the last three months. Corporate insiders own 2.62% of the company's stock.

Owens & Minor Price Performance

Shares of NYSE:OMI traded down $0.32 during trading on Thursday, reaching $7.13. 788,933 shares of the company traded hands, compared to its average volume of 1,068,451. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a 52 week low of $6.07 and a 52 week high of $26.37. The firm has a market capitalization of $550.62 million, a PE ratio of -11.04, a PEG ratio of 0.20 and a beta of 1.02. The company's 50 day moving average is $8.53 and its two-hundred day moving average is $11.89.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The company reported $0.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.02. The firm had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business's revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.69 earnings per share. As a group, sell-side analysts predict that Owens & Minor, Inc. will post 1.51 earnings per share for the current year.

Owens & Minor announced that its Board of Directors has initiated a stock repurchase plan on Friday, February 28th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 13.6% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's management believes its stock is undervalued.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.